By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mirati Therapeutics 

9363 Towne Centre Drive
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-535-2075 Fax: n/a


Key Statistics

Email: n/a
Ownership: Public

Web Site: Mirati Therapeutics
Symbol: MRTX

Company News
Mirati Therapeutics  (MRTX) Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer 9/15/2017 6:49:28 AM
Mirati Therapeutics  (MRTX) To Participate In Immuno-Oncology Panel Discussion At The 2017 Citi Biotech Conference 8/31/2017 6:27:56 AM
Mirati Therapeutics  (MRTX) Reports Second Quarter 2017 Financial Results 8/4/2017 9:19:21 AM
Mirati Therapeutics  (MRTX) To Host Key Opinion Leader Breakfast On Immuno-Oncology Combinations On July 11 In New York 7/6/2017 9:01:44 AM
Mirati Therapeutics  (MRTX) Announces Appointment Of Neil Reisman To The Board Of Directors 6/28/2017 7:32:49 AM
Mirati Therapeutics  (MRTX) To Present At The 2017 Jefferies Global Healthcare Conference 6/1/2017 2:24:21 PM
Mirati Therapeutics  (MRTX) Reports First Quarter 2017 Financial Results 5/5/2017 8:44:02 AM
Mirati Therapeutics  (MRTX) Reports Financial Results And Provides Business Update For The Fourth Quarter And Full Year 2016 3/10/2017 7:31:05 AM
Mirati Therapeutics  (MRTX) To Present At Leerink Partners 6th Annual Global Healthcare Conference 2/14/2017 9:05:16 AM
Mirati Therapeutics  (MRTX) Release: Pharma Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriter's Option To Purchase Additional Shares 1/12/2017 6:04:42 AM